0% chance they would not go through with the R/M, as they already have their name all over the deal. They did not spend all this time and money and years and research at UPennMed to quit now. If they were quitters they would not have even tried again.
Larry Kubin, Major shareholder of the Biotech going public by R/M with $MILV, two time NFL football linebacker would not stop and walk away 1" from the end zone, 1" from a touch down in the last minutes of the big game.
He is in it, in this company for philanthropic reasons like many of us, including me (not just for money), to get #TBI Traumatic Brain Injury NDT Pharmaceutical Tech onto the market that can help the brain repair itself by delivering non-drug nutrients in stealth Nano Particle Complex vessels that can cross the blood brain Barrier, to the brain!!!!
Second stage is licensing it to major firms like Novartis (a 300 billion dollar biotech I also own shares in) for drug trials, for use to carry Rx drugs that target cancer cells one cell at time like a heat seeking missile.
If They want to raise money later this year, they need market cap, and a R/S would kill the market cap and end chances of this ever raising real Biotech money. These folks are not stupid!!!! Scams that want print and dump shares to pay off toxic note debt, do R/S's.
Ever wondered if endeavor toxic note folks were left to stew in the mess they created, a mess of their own making, left to stew because they refused to work with Hovis in 2016, and now want revenge by attacking this Hovis Biotech R/M Biotech Birth they missed out on, with fake news, because they were too greedy to get a shot at it and missed the boat????
News 
Market Data 
Discover 
AI
